ANI PHARMACEUTICALS, INC Income Taxes Paid
ANI PHARMACEUTICALS, INC (ANIP) reported Income Taxes Paid of $12.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC income taxes paid, net for the quarter ending 2026-06-30 was $19.00M, a 17.39% increase year-over-year.
- ANI PHARMACEUTICALS, INC income taxes paid, net for the quarter ending 2026-03-31 was -$6.07M, a 2228.07% decline year-over-year.
- ANI PHARMACEUTICALS, INC income taxes paid, net for the quarter ending 2025-06-30 was $16.19M.
- ANI PHARMACEUTICALS, INC income taxes paid, net for the quarter ending 2025-03-31 was $285.00K.
- ANI PHARMACEUTICALS, INC income taxes paid, net for fiscal 2025 was $17.67M.
- ANI PHARMACEUTICALS, INC income taxes paid, net for fiscal 2016 was $9.54M, a 28.05% decline from fiscal 2015.
- ANI PHARMACEUTICALS, INC income taxes paid, net for fiscal 2015 was $13.26M, a 8917.01% increase from fiscal 2014.
- ANI PHARMACEUTICALS, INC income taxes paid, net for fiscal 2014 was $147.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $12.94M 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | -$6.07M 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $17.67M 10-K · filed 2026-02-27 | |||
| 2025-06-30 | $16.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $16.47M 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | $285.00K 10-Q · filed 2026-05-08 | |||
| 2017-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $12.49M derived: sum of 2 quarters · filed 2017-11-02 | $12.49M 10-Q · filed 2017-11-02 | $16.18M derived: sum of 4 quarters · filed 2017-11-02 |
| 2017-06-30 | $9.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $9.88M 10-Q · filed 2017-08-03 | $13.57M derived: sum of 3 quarters · filed 2017-08-03 | $17.21M derived: sum of 4 quarters · filed 2017-11-02 |
| 2017-03-31 | $4.00K 10-Q · filed 2017-05-04 | $3.69M derived: sum of 2 quarters · filed 2017-05-04 | $7.33M derived: sum of 3 quarters · filed 2017-11-02 | $7.90M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $7.33M derived: sum of 2 quarters · filed 2017-11-02 | $7.89M derived: sum of 3 quarters · filed 2017-11-02 | $9.54M 10-K · filed 2017-03-02 |
| 2016-09-30 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.20M derived: sum of 2 quarters · filed 2017-11-02 | $5.85M 10-Q · filed 2017-11-02 | $8.43M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | $563.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.21M 10-Q · filed 2017-08-03 | $4.79M derived: sum of 3 quarters · filed 2017-08-03 | $6.01M derived: sum of 4 quarters · filed 2017-08-03 |
| 2016-03-31 | $1.64M 10-Q · filed 2017-05-04 | $4.23M derived: sum of 2 quarters · filed 2017-05-04 | $5.45M derived: sum of 3 quarters · filed 2017-05-04 | $8.87M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $3.81M derived: sum of 2 quarters · filed 2017-03-02 | $7.23M derived: sum of 3 quarters · filed 2017-03-02 | $13.26M 10-K · filed 2017-03-02 |
| 2015-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.64M derived: sum of 2 quarters · filed 2016-11-03 | $10.67M 10-Q · filed 2016-11-03 | $10.68M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $9.45M 10-Q · filed 2016-08-04 | $9.46M derived: sum of 3 quarters · filed 2017-03-02 | $9.54M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | $6.03M 10-Q · filed 2016-05-05 | $6.04M derived: sum of 2 quarters · filed 2017-03-02 | $6.12M derived: sum of 3 quarters · filed 2017-03-02 | $6.12M derived: sum of 4 quarters · filed 2017-03-02 |
| 2014-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $87.00K derived: sum of 2 quarters · filed 2017-03-02 | $87.00K derived: sum of 3 quarters · filed 2017-03-02 | $147.00K 10-K · filed 2017-03-02 |
| 2014-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $77.00K derived: sum of 2 quarters · filed 2015-11-03 | $137.00K 10-Q · filed 2015-11-03 | $137.00K derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $60.00K 10-Q · filed 2015-08-04 | $60.00K derived: sum of 3 quarters · filed 2016-02-23 | $60.00K derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $60.00K 10-Q · filed 2015-05-05 | $60.00K derived: sum of 2 quarters · filed 2016-02-23 | $60.00K derived: sum of 3 quarters · filed 2016-02-23 | $60.00K derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-23 | $0.00 10-K · filed 2016-02-23 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |